Efficacy of Erythropoietin-Beta Injections During Autologous Blood Donation Before Spinal Deformity Surgery in Children and Teenagers.
METHODS
Retrospective observational study OBJECTIVE.: To clarify the efficacy of recombinant human erythropoietin-beta (EPO-beta) injections during autologous blood donation (ABD) before spinal deformity surgery in children and teenagers.


BACKGROUND
ABD is preferred for spinal deformity surgery. A few studies have assessed the usefulness of preoperative ABD with EPO-beta in anemic patients.


METHODS
Fifty-six spinal deformity surgery patients (41 females, 15 males; median age: 15 yrs; range, 5-19 yrs) underwent preoperative ABD. ABD was performed weekly according to the patient's body weight with a subcutaneous EPO-beta injection (24,000 U). The collected blood volumes were compared among the low hemoglobin (low-Hb) (<13 g/dL), mid-Hb (13-13.9 g/dL), and high-Hb (≥14 g/dL) groups using the Kruskal-Wallis test. The effects of EPO-beta injection on the Hb levels were estimated using a linear mixed model.


RESULTS
The patients underwent a median of four ABD collections (range, two to six). The median collected volume per ABD was 200 mL (range, 40-400 mL). The median total blood collection was 700 mL (range, 160-1,350 mL); the corresponding values were 700 mL, 700 mL, and 800 mL in the low-Hb, mid-Hb, and high-Hb groups, respectively (P = 0.964). The median blood loss was 500 mL (range, 10-2,940 mL); 53 out of 55 patients (96%) did not require unplanned allogeneic transfusion, including 11 out of 12 (92%) cases with blood loss >1,000 mL. The additional recovery of Hb levels with one EPO-beta injection was 0.29 ± 0.14 g/dL (P = 0.039) after adjusting for confounding factors.


CONCLUSIONS
ABD with an EPO-beta injection is useful for avoiding allogeneic transfusion during spinal deformity surgery in children and teenagers, and patients in the low-Hb group achieved ABD volumes equivalent to those in the high-Hb group. Thus, an additional recovery of Hb levels of 0.29 g/dL per injection can be expected after 1 week.


METHODS
4.
*Department of Orthopedic Surgery, Shinshu University School of Medicine, Matsumoto City, Nagano, Japan †Division of Transfusion Medicine, Cell Processing Center, Shinshu University Hospital, Matsumoto City, Nagano, Japan.
Shota
S
Ikegami
Jun
J
Takahashi
Shugo
S
Kuraishi
Masayuki
M
Shimizu
Toshimasa
T
Futatsugi
Masashi
M
Uehara
Kayo
K
Horiuchi
Shigetaka
S
Shimodaira
Hiroyuki
H
Kato
D000293:Adolescent; D000328:Adult; D001782:Blood Donors; D001804:Blood Transfusion, Autologous / Q000706:statistics & numerical data*; D002648:Child; D002675:Child, Preschool; D004921:Erythropoietin / Q000008:administration & dosage / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D011994:Recombinant Proteins / Q000008:administration & dosage / Q000627:therapeutic use*; D013122:Spinal Diseases / Q000601:surgery; D013131:Spine / Q000002:abnormalities* / Q000601:surgery*; D055815:Young Adult
D011994:Recombinant Proteins; D004921:Erythropoietin